Published in

American Academy of Neurology (AAN), Neurology, 7(61), p. 897-902, 2003

DOI: 10.1212/01.wnl.0000086903.69738.dc

Links

Tools

Export citation

Search in Google Scholar

Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy

Journal article published in 2003 by Robert J. Simister, Mary A. McLean ORCID, Gareth J. Barker ORCID, John S. Duncan
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective: To assess gamma-aminobutyric acid (GABA) plus homocarnosine (GABA+) and glutamate plus glutamine (GLX) concentrations in the frontal lobes of patients with idiopathic generalized epilepsy (IGE). Methods: Twenty-one patients and 17 healthy volunteers were studied. A single voxel was prescribed in each frontal lobe for each subject. Point-resolved spectroscopy (PRESS)-localized short echo time MR spectroscopy (MRS) was performed to measure GLX and the metabolites N-acetylaspartate plus N-acetylaspartylglutamate (NAAt), creatine and phosphocreatine (Cr), choline-containing compounds (Cho), and myo-inositol (Ins). A double quantum GABA filter was used to measure GABA+. Segmented T1-weighted images gave the tissue composition of the prescribed voxel. Results: Group comparisons showed elevation of GLX and reduction of NAAt in the patient group (p